Vicarious Surgical Inc. (RBOT) - Net Assets
Based on the latest financial reports, Vicarious Surgical Inc. (RBOT) has net assets worth $14.09 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($29.35 Million) and total liabilities ($15.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RBOT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.09 Million |
| % of Total Assets | 48.0% |
| Annual Growth Rate | 24.46% |
| 5-Year Change | 177.09% |
| 10-Year Change | N/A |
| Growth Volatility | 161.93 |
Vicarious Surgical Inc. - Net Assets Trend (2019–2024)
This chart illustrates how Vicarious Surgical Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore how large is Vicarious Surgical Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Vicarious Surgical Inc. (2019–2024)
The table below shows the annual net assets of Vicarious Surgical Inc. from 2019 to 2024. For live valuation and market cap data, see market value of Vicarious Surgical Inc..
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $46.70 Million | -52.33% |
| 2023-12-31 | $97.97 Million | -11.78% |
| 2022-12-31 | $111.05 Million | +33.64% |
| 2021-12-31 | $83.09 Million | +393.03% |
| 2020-12-31 | $16.85 Million | +7.81% |
| 2019-12-31 | $15.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Vicarious Surgical Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17721900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $17.00K | 0.04% |
| Other Comprehensive Income | $50.00K | 0.11% |
| Other Components | $242.57 Million | 519.44% |
| Total Equity | $46.70 Million | 100.00% |
Vicarious Surgical Inc. Competitors by Market Cap
The table below lists competitors of Vicarious Surgical Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
District Copper Corp
V:DCOP
|
$2.72 Million |
|
Henry Boot PLC
LSE:BOOT
|
$2.72 Million |
|
Discovery Alaska Ltd
AU:DAF
|
$2.72 Million |
|
Vistal Gdynia
WAR:VTL
|
$2.72 Million |
|
Millennium Food-Tech LP
TA:MIFT
|
$2.71 Million |
|
WINDELN.DE SE INH O.N.
F:WDL1
|
$2.71 Million |
|
FAT Brands Inc
NASDAQ:FAT
|
$2.71 Million |
|
Capella Minerals Ltd
V:CMIL
|
$2.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vicarious Surgical Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 97,969,000 to 46,698,000, a change of -51,271,000 (-52.3%).
- Net loss of 63,223,000 reduced equity.
- Other comprehensive income increased equity by 40,000.
- Other factors increased equity by 11,912,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-63.22 Million | -135.39% |
| Other Comprehensive Income | $40.00K | +0.09% |
| Other Changes | $11.91 Million | +25.51% |
| Total Change | $- | -52.33% |
Book Value vs Market Value Analysis
This analysis compares Vicarious Surgical Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $2.86 | $0.42 | x |
| 2020-12-31 | $4.92 | $0.42 | x |
| 2021-12-31 | $25.80 | $0.42 | x |
| 2022-12-31 | $26.15 | $0.42 | x |
| 2023-12-31 | $20.13 | $0.42 | x |
| 2024-12-31 | $7.93 | $0.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vicarious Surgical Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -135.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.45x
- Recent ROE (-135.39%) is below the historical average (-63.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -59.58% | 0.00% | 0.00x | 1.05x | $-10.88 Million |
| 2020 | -76.40% | 0.00% | 0.00x | 1.06x | $-14.56 Million |
| 2021 | -42.37% | 0.00% | 0.00x | 2.19x | $-43.52 Million |
| 2022 | 4.64% | 0.00% | 0.00x | 1.26x | $-5.95 Million |
| 2023 | -72.54% | 0.00% | 0.00x | 1.22x | $-80.87 Million |
| 2024 | -135.39% | 0.00% | 0.00x | 1.45x | $-67.89 Million |
Industry Comparison
This section compares Vicarious Surgical Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,473,793,506
- Average return on equity (ROE) among peers: -74.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vicarious Surgical Inc. (RBOT) | $14.09 Million | -59.58% | 1.08x | $2.71 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $150.06 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $20.56 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $14.38 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $7.86 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.39 Million |
| Artivion Inc (AORT) | $275.07 Million | -1.38% | 1.08x | $1.66 Billion |
| Apyx Medical Inc (APYX) | $4.69 Million | -368.17% | 4.29x | $119.81 Million |
About Vicarious Surgical Inc.
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.